Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr;170A(4):999-1006.
doi: 10.1002/ajmg.a.37537. Epub 2016 Jan 6.

Novel features of 3q29 deletion syndrome: Results from the 3q29 registry

Affiliations

Novel features of 3q29 deletion syndrome: Results from the 3q29 registry

Megan R Glassford et al. Am J Med Genet A. 2016 Apr.

Abstract

3q29 deletion syndrome is caused by a recurrent, typically de novo heterozygous 1.6 Mb deletion, but because incidence of the deletion is rare (1 in 30,000 births) the phenotype is not well described. To characterize the range of phenotypic manifestations associated with 3q29 deletion syndrome, we have developed an online registry (3q29deletion.org) for ascertainment of study subjects and phenotypic data collection via Internet-based survey instruments. We report here on data collected during the first 18 months of registry operation, from 44 patients. This is the largest cohort of 3q29 deletion carriers ever assembled and surveyed in a systematic way. Our data reveal that 28% of registry participants report neuropsychiatric phenotypes, including anxiety disorder, panic attacks, depression, bipolar disorder, and schizophrenia. Other novel findings include a high prevalence (64%) of feeding problems in infancy and reduced weight at birth for 3q29 deletion carriers (average reduction 13.9 oz (394 g), adjusted for gestational age and sex, P = 6.5e-07). We further report on the frequency of heart defects, autism, recurrent ear infections, gastrointestinal phenotypes, and dental phenotypes, among others. We also report on the expected timing of delayed developmental milestones. This is the most comprehensive description of the 3q29 deletion phenotype to date. These results are clinically actionable toward improving patient care for 3q29 deletion carriers, and can guide the expectations of physicians and parents. These data also demonstrate the value of patient-reported outcomes to reveal the full phenotypic spectrum of rare genomic disorders.

Keywords: 3q29 deletion; 3q29 microdeletion; autism spectrum disorder; copy number variation; developmental delay; genomic disorders; patient-reported outcomes; schizophrenia.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The distribution of birth weight (blue) and gestational age (red) in the 3q29 deletion registry population (top) and US natality data for 2012 (bottom). There are differences in birth weight (3q29 deletion registry participants, mean = 6.09 lbs; 2012 US general population, mean = 7.2 lbs) and gestational age (3q29 deletion registry participants, mean = 37.95 w; 2012 US general population, mean = 38.71 w). After adjusting for sex and gestational age, 3q29 deletion carriers are predicted to weigh 0.86 lbs less at birth than babies in the general population. [Color figure can be seen in the online version of this article, available at http://wileyonlinelibrary.com/journal/ajmga].
Figure 2
Figure 2
Problems in the first year of life reported in 3q29 deletion registry participants. [Color figure can be seen in the online version of this article, available at http://wileyonlinelibrary.com/journal/ajmga].
Figure 3
Figure 3
Time‐to‐event curves for four exemplar developmental milestones. The dashed green line indicates the time at which 50% of typically developing children achieve the milestone [Dosman et al., 2012]; the dashed blue line indicates when 50% of 3q29 deletion registry participants are reported to achieve the same milestone. [Color figure can be seen in the online version of this article, available at http://wileyonlinelibrary.com/journal/ajmga].
Figure 4
Figure 4
The distribution of neuropsychiatric conditions reported by 3q29 deletion registry participants. [Color figure can be seen in the online version of this article, available at http://wileyonlinelibrary.com/journal/ajmga].

References

    1. Antonacci F, Kidd JM, Marques‐Bonet T, Teague B, Ventura M, Girirajan S, Alkan C, Campbell CD, Vives L, Malig M, Rosenfeld JA, Ballif BC, Shaffer LG, Graves TA, Wilson RK, Schwartz DC, Eichler EE. 2010. A large and complex structural polymorphism at 16p12.1 underlies microdeletion disease risk. Nat Genet 42:745–750. - PMC - PubMed
    1. Antonacci F, Kidd JM, Marques‐Bonet T, Ventura M, Siswara P, Jiang Z, Eichler EE. 2009. Characterization of six human disease‐associated inversion polymorphisms. Hum Mol Genet 18:2555–2566. - PMC - PubMed
    1. Ballif BC, Theisen A, Coppinger J, Gowans GC, Hersh JH, Madan‐Khetarpal S, Schmidt KR, Tervo R, Escobar LF, Friedrich CA, McDonald M, Campbell L, Ming JE, Zackai EH, Bejjani BA, Shaffer LG. 2008. Expanding the clinical phenotype of the 3q29 microdeletion syndrome and characterization of the reciprocal microduplication. Mol Cytogenet 1:8. - PMC - PubMed
    1. Citta S, Buono S, Greco D, Barone C, Alfei E, Bulgheroni S, Usilla A, Pantaleoni C, Romano C. 2013. 3q29 microdeletion syndrome: Cognitive and behavioral phenotype in four patients. Am J Med Genet A 161A:3018–3022. - PubMed
    1. Clayton‐Smith J, Giblin C, Smith RA, Dunn C, Willatt L. 2010. Familial 3q29 microdeletion syndrome providing further evidence of involvement of the 3q29 region in bipolar disorder. Clin Dysmorphol 19:128–132. - PubMed

Publication types